Please join us for a wide-ranging discussion on foreign investments in life sciences, international licensing trends, and the Chinese and Japanese environment for US biotech.

We will discuss the new powers of the Committee on Foreign Investment in the United States (CFIUS), the CFIUS pilot program, the definition of critical technologies and how companies are approaching CFIUS risks. We will also explore how startups and venture funds are electing to take practical steps to limit or allocate CFIUS risk, and when and how those investors and companies are electing to file with CFIUS.

PANEL:

Jason Skolnik, Partner, WSGR
Josh Gruenspecht, Of counsel, WSGR
Chris LeMasters, Chief Business Officer, Mirati Therapeutics
Jason Brown, Managing Director, C-Bridge Capital

DETAILS:

Where: Wilson Sonsini Goodrich & Rosati
12235 El Camino Real
San Diego, CA 92130

When: Thursday, March 14, 2019
7:30 AM – 9:00 AM

Fee: $35 for Members/$50 for Non-members
(Please bring your check to the meeting)

Please RSVP no later than Monday, March 11th to
Vanessa Jacoby via email at vanessa@aviditybio.com

At our March 2019 meeting, we will be raffling off a free registration to the National Conference in Boston! You will receive a virtual raffle ticket for each event you attend for January and February 2019 and an extra raffle ticket if you bring a friend to a breakfast meeting and they sign up to be a member of ABFO.

Looking forward to seeing you there!